| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDXS | Common Stock | Options Exercise | $70,357 | +35,714 | +4.6% | $1.97 | 819,679 | 15 Mar 2023 | Direct | F1 |
| transaction | CDXS | Common Stock | Sale | $146,131 | -35,714 | -4.4% | $4.09 | 783,965 | 15 Mar 2023 | Direct | F1, F2 |
| transaction | CDXS | Common Stock | Options Exercise | $70,357 | +35,714 | +4.6% | $1.97 | 819,679 | 16 Mar 2023 | Direct | F1 |
| transaction | CDXS | Common Stock | Sale | $146,681 | -35,714 | -4.4% | $4.11 | 783,965 | 16 Mar 2023 | Direct | F1, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDXS | Stock Option (Right to Buy) | Options Exercise | $0 | -35,714 | -12% | $0.000000 | 249,998 | 15 Mar 2023 | Common Stock | 35,714 | $1.97 | Direct | F1 |
| transaction | CDXS | Stock Option (Right to Buy) | Options Exercise | $0 | -35,714 | -14% | $0.000000 | 214,284 | 16 Mar 2023 | Common Stock | 35,714 | $1.97 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022. |
| F2 | This transaction was executed in multiple trades in prices ranging from $4.02 to $4.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F3 | This transaction was executed in multiple trades in prices ranging from $4.01 to $4.195, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |